BIRC5 and breast carcinoma: For example, BIRC5 (Survivin) is a well-known anti-apoptotic protein associated with drug resistance and poor prognosis,28 targeted drugs such as YM155 have been tested in clinical trials for breast cancer and non-small cell lung cancer.29